NCT01490190View on ClinicalTrials.gov

Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

PHASE4CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

December 26, 2011

Primary Completion Date

December 5, 2012

Study Completion Date

December 5, 2012

Conditions
Contraception
Interventions
DRUG

Ethinylestradiol + Etonogestrel Vaginal Ring (NuvaRing)

Three cycles of NuvaRing use, each cycle consisting of etonogestrel 0.120 mg and ethinylestradiol 0.015 mg over a period of 21 days followed by 7 ring-free days.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01490190 - Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733) | Biotech Hunter | Biotech Hunter